Lymphatics in intestinal transport of nutrients and gastrointestinal hormones

Annals of the New York Academy of Sciences

Volumn 1207, Issue SUPPL.1, 2010, Pages

  Kohan, Alison ^a   Yoder, Stephanie ^a   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Chylomicron; Fat absorption; Incretins; Lymph fistula model; Lymphatics

Indexed keywords

DIPEPTIDYL PEPTIDASE; GASTROINTESTINAL HORMONE; INCRETIN; TRIACYLGLYCEROL; APOLIPOPROTEIN; BILE ACID; FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTESTINE ABSORPTION; INTESTINE CELL; LIPID ABSORPTION; LYMPH VESSEL; LYMPHATIC SYSTEM; MICELLE; NONHUMAN; NUTRIENT UPTAKE; PATHOPHYSIOLOGY; RAT; ANIMAL; ELECTRON MICROSCOPY; METABOLISM; PHYSIOLOGY; REVIEW; SECRETION;

ANIMALIA; FISTULA; RATTUS;

ANIMALS; APOLIPOPROTEINS; BILE ACIDS AND SALTS; FATTY ACIDS; GASTROINTESTINAL HORMONES; INTESTINAL ABSORPTION; LYMPHATIC VESSELS; MICROSCOPY, ELECTRON; RATS; TRIGLYCERIDES;

EID: 78049507684     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05753.x     Document Type: Article

References (59)

1. Tso, P. 1985. Gastrointestinal digestion and absorption of lipid. Adv. Lipid. Res. 21: 143-186.
2. Thomson, A.B. et al. 1989. Intestinal aspects of lipid absorption: in review. Can. J. Physiol. Pharmacol. 67: 179-191.
3. Morgan, R.G., J. Barrowman & B. Borgstrom. 1969. The effect of sodium taurodesoxycholate and pH on the gel filtration behavior of rat pancreatic protein and lipases. Biochim. Biophys. Acta 175: 65-75.
4. Erlanson-Albertsson, C. 1992. Pancreatic colipase. Structural and physiological aspects. Biochim. Biophys. Acta 1125: 1-7.
5. Savary, P., M.J. Constantin & P. Desnuelle. 1961. On the structure of the triglycerides of the lymphatic chylomicrons in the rat. Biochim. Biophys. Acta 48: 562-571.
6. Sternby, B. & B. Borgstrom. 1979. Purification and characterization of human pancreatic colipase. Biochim. Biophys. Acta 572: 235-243.
7. Breckenridge, W.C., L. Marai & A. Kuksis. 1969. Triglyceride structure of human milk fat. Can. J. Biochem. 47: 761-769.
8. Abrams, C.K. et al. 1988. Gastric lipase: localization in the human stomach. Gastroenterology 95: 1460-1464.
9. Borgstrom, B. 1985. The micellar hypothesis of fat absorption: must it be revisited? Scand. J. Gastroenterol. 20: 389-394.
10. Hofmann, A.F. & B. Borgstroem. 1964. The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J. Clin. Invest. 43: 247-257.
11. Hofmann, A.F.&B.Borgstrom. 1962. Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed. Proc. 21: 43-50.
12. Bass, N.M. 1988. The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int. Rev. Cytol. 111: 143-184.
13. Glatz, J.F. & J.H. Veerkamp. 1985. Intracellular fatty acidbinding proteins. Int. J. Biochem. 17: 13-22.
14. Storch, J. & L. McDermott. 2009. Structural and functional analysis of fatty acid-binding proteins. J. Lipid Res. 50(Suppl.): S126-S131.
15. Manganaro, F. & A. Kuksis. 1985. Purification and preliminary characterization of 2-monoacylglycerol acyltransferase from rat intestinal villus cells. Can. J. Biochem. Cell Biol. 63: 341-347.
16. Rao, G.A. & J.M. Johnston. 1966. Purification and properties of triglyceride synthetase from the intestinal mucosa. Biochim. Biophys. Acta 125: 465-473.
17. Hayashi, H. et al. 1990. Fat feeding increases size, but not number, of chylomicrons produced by small intestine. Am. J. Physiol. 259: G709-G719.
18. Bhattacharya, S. & T.G. Redgrave. 1981. The content of apolipoprotein B in chylomicron particles. J. Lipid Res. 22: 820-828.
19. Martins, I.J. et al. 1994. Lipid and apolipoprotein B48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulindeficient rats. Diabetologia 37: 238-246.
20. Lo, C.M. et al. 2008. Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation? Am. J. Physiol. Gastrointest. Liver Physiol. 294: G344-G352.
21. Tso, P., J.A. Barrowman & D.N. Granger. 1986. Importance of interstitial matrix hydration in intestinal chylomicron transport. Am. J. Physiol. 250: G497-G500.
22. Tso, P., V. Pitts & D.N. Granger. 1985. Role of lymph flow in intestinal chylomicron transport. Am. J. Physiol. 249: G21- G28.
23. Sabesin, S.M. & S. Frase. 1977. Electron microscopic studies of the assembly, intracellular transport, and secretion of chylomicrons by rat intestine. J. Lipid Res. 18: 496-511.
24. Kondoh, M. & K. Yagi. 2007. Progress in absorption enhancers based on tight junction. Expert Opin. Drug Deliv. 4: 275-286.
25. Ilback, N.G. et al. 2004. Do surface-active lipids in food increase the intestinal permeability to toxic substances and allergenic agents? Med. Hypotheses 63: 724-730.
26. Kvietys, P.R. et al. 1991. Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion. Am. J. Physiol. 261: G384-G391.
27. Hayashi, H. et al. 1990. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J. Lipid Res. 31: 1613-1625.
28. Tso, P. & S.R. Gollamudi. 1984. Pluronic L-81: a potent inhibitor of the transport of intestinal chylomicrons. Am. J. Physiol. 247: G32-G36.
29. Tso, P. et al. 1982. Maximal lymphatic triglyceride transport rate from the rat small intestine. Am. J. Physiol. 242: G408- G415.
30. Tso, P. et al. 1981. Acute inhibition of intestinal lipid transport by pluronic L-81 in the rat. Am. J. Physiol. 241: G487- G497.
31. Tso, P. & J.A. Balint. 1986. Formation and transport of chylomicrons by enterocytes to the lymphatics. Am. J. Physiol. 250: G715-G726.
32. Hirano, K. et al. 1996. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 271: 9887-9890.
33. Brown, J.C., V.Mutt&R.A.Pederson. 1970. Further purification of a polypeptide demonstrating enterogastrone activity. J. Physiol. 209: 57-64.
34. Schmidt, W.E., E.G. Siegel&W.Creutzfeldt. 1985. Glucagonlike peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28: 704-707.
35. Vilsboll, T. et al. 2003. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul. Pept. 114: 115-121.
36. Kim, S.J. et al. 2005. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J. Biol. Chem. 280: 22297-22307.
37. Wang, Y. et al. 1996. GIP regulates glucose transporters, hexokinases, and glucose-induced insulin secretion in RIN 1046-38 cells. Mol. Cell. Endocrinol. 116: 81-87.
38. Getty-Kaushik, L. et al. 2006. Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification. Obesity (Silver Spring). 14: 1124-1131.
39. Miyawaki, K. et al. 2002. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat. Med. 8: 738-742.
40. Deacon, C.F. 2005. What do we know about the secretion and degradation of incretin hormones? Regul. Pept. 128: 117-124.
41. Layer, P. et al. 1990. Human pancreatic secretion and intestinal motility: effects of ileal nutrient perfusion. Am. J. Physiol. 258: G196-G201.
42. Maljaars, P.W. et al. 2008. Ileal brake: a sensible food target for appetite control. A review. Physiol. Behav. 95: 271-281.
43. Nauck, M.A. et al. 1997. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am. J. Physiol. 273: E981-E988.
44. Spiller, R.C. et al. 1988. Further characterisation of the 'ileal brake' reflex in man-effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 29: 1042-1051.
45. Gutzwiller, J.P. et al. 1999. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 44: 81-86.
46. Naslund, E. et al. 1999. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int. J. Obes. Relat. Metab. Disord. 23: 304-311.
47. Turton, M.D. et al. 1996. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72.
48. Larsen, P.J. et al. 2001. Systemic administration of the longacting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes 50: 2530-2539.
49. D'Alessio, D. et al. 2007. Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system.Am. J. Physiol. Regul. Integr. Comp. Physiol. 293: R2163-R2169.
50. Kieffer, T.J., C.H. McIntosh & R.A. Pederson. 1995. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136: 3585-3596.
51. Mentlein, R., B. Gallwitz &W.E. Schmidt. 1993. Dipeptidylpeptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur. J. Biochem. 214: 829-835.
52. Nagatsu, T. et al. 1976. New chromogenic substrates for Xprolyl dipeptidyl-aminopeptidase. Anal. Biochem. 74: 466-476.
53. Barrowman, J.A. 1978. Physiology of the Gastro-intestinal Lymphatic System. Cambridge University Press. Cambridge, England; New York.
54. Yang, Y.J. et al. 1989. Insulin transport across capillaries is rate limiting for insulin action in dogs. J. Clin. Invest. 84: 1620-1628.
55. Sjolund, K. et al. 1983. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 85: 1120-1130.
56. Lewin, K.J. 1986. The endocrine cells of the gastrointestinal tract. The normal endocrine cells and their hyperplasias. Part I. Pathol. Annu. 21(Pt 1): 1-27.
57. Lu, W.J. et al. 2008. Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G1130-G1138.
58. Falko, J.M. et al. 1975. Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J. Clin. Endocrinol.Metab. 41: 260-265.
59. Murphy, M.C. et al. 1995. Postprandial lipid and hormone responses to meals of varying fat contents: modulatory role of lipoprotein lipase? Eur. J. Clin. Nutr. 49: 578-588.